End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58,500 KRW | +1.92% | -0.34% | -18.75% |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Mar. 07 | SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline | CI |
Sales 2024 * | 246B 178M | Sales 2025 * | 320B 233M | Capitalization | 4,494B 3.26B |
---|---|---|---|---|---|
Net income 2024 * | -38B -27.59M | Net income 2025 * | -18B -13.07M | EV / Sales 2024 * | 17.5 x |
Net cash position 2024 * | 200B 145M | Net cash position 2025 * | 498B 362M | EV / Sales 2025 * | 12.5 x |
P/E ratio 2024 * |
-116
x | P/E ratio 2025 * |
-243
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.47% |
1 day | +1.92% | ||
1 week | -0.34% | ||
Current month | -4.57% | ||
1 month | -7.14% | ||
3 months | -6.85% | ||
6 months | +0.17% | ||
Current year | -18.75% |
Managers | Title | Age | Since |
---|---|---|---|
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Yong-Sung Choi
DFI | Director of Finance/CFO | 51 | - |
Sally Choe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Choi
BRD | Director/Board Member | 60 | - |
Chang-Jin Moon
BRD | Director/Board Member | 71 | - |
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 16 M€ | -7.93% | ||
0.04% | 15 M€ | +7.47% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 58,500 | +1.92% | 41,381 |
24-04-19 | 57,400 | -1.37% | 72,574 |
24-04-18 | 58,200 | +2.65% | 66,566 |
24-04-17 | 56,700 | -0.53% | 59,833 |
24-04-16 | 57,000 | -2.90% | 113,335 |
End-of-day quote Korea S.E., April 21, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.75% | 3.26B | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
-24.99% | 28.22B | |
+56.02% | 24.64B | |
-7.19% | 16.98B | |
-34.20% | 13.29B | |
-17.31% | 11.66B | |
-11.43% | 11.65B | |
-1.05% | 8.18B |
- Stock Market
- Equities
- A302440 Stock